| GSE67980 | GSM1660178 | AB 5500xl Genetic Analyzer | Homo sapiens | Pr21.1.7 | lineage-confirmed PCa CTC CRPC progressed on enzalutamide (Group B) | donor: Pr21; donor type: CRPC; enzalutamide: progressed on enzalutamide (Group B) |
| GSE69405 | GSM1702726 | Illumina HiSeq 2500 | Homo sapiens | LC-PT-45-Re_SC91 | PDX, LC-PT-45-Re | cell type: PDX |
| GSE70580 | GSM1810681 | Illumina HiSeq 2000 | Homo sapiens | T75_P2_D12_ILC3 | Donor T75-tonsil innate lymphoid cell (ILC3) | tonsil donor: Donor T75; facs gating: ILC3; cell type: tonsil Innate lymphoid cells |
| GSE70580 | GSM1810937 | Illumina HiSeq 2000 | Homo sapiens | T86_P2_A12_ILC2 | Donor T86-tonsil innate lymphoid cell (ILC2) | tonsil donor: Donor T86; facs gating: ILC2; cell type: tonsil Innate lymphoid cells |
| GSE71315 | GSM1832379 | Illumina HiSeq 2500 | Homo sapiens | A1_N704_S502 | Cerebral Cortex GW20.5 | tissue: Cerebral Cortex; developmental stage: GW20.5 |
| GSE71858 | GSM1846950 | Illumina HiSeq 2500 | Homo sapiens | Live_PLRC [US-1457350-11] | cultured embryonic stem cells (H1) DAPI- Live cells FRSCR | cell line: H1; cell type: cultured embryonic stem cells; phenotype: DAPI-; sample group: Live cells_FRSCR |
| GSE72056 | GSM1850751 | Illumina NextSeq 500 | Homo sapiens | CY58_1_CD45_F08_S1028_comb | melanoma tumor | tumor-of-origin: CY58 |
| GSE72056 | GSM1851007 | Illumina NextSeq 500 | Homo sapiens | Cy71_CD45_G10_S562_comb | T-cell | tumor-of-origin: Cy71 |
| GSE72056 | GSM1851263 | Illumina NextSeq 500 | Homo sapiens | cy79-p1-CD45-neg-PDL1-neg-AS-C4-R1-A12-S108-comb | melanoma | tumor-of-origin: cy79 |
| GSE72056 | GSM1851519 | Illumina NextSeq 500 | Homo sapiens | cy79-p1-CD45-pos-PD1-pos-AS-C5-R1-B07-S211-comb | T-cell | tumor-of-origin: cy79 |
